{"id":"NCT02797132","sponsor":"Vertex Pharmaceuticals Incorporated","briefTitle":"Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del","officialTitle":"A Phase 3, 2-Part, Open-label Study to Evaluate the Safety and Pharmacokinetics of Lumacaftor/Ivacaftor Combination Therapy in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05","primaryCompletion":"2017-09","completion":"2017-09","firstPosted":"2016-06-13","resultsPosted":"2018-10-30","lastUpdate":"2018-10-30"},"enrollment":62,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cystic Fibrosis"],"interventions":[{"type":"DRUG","name":"LUM/IVA","otherNames":["Orkambi","VX-809+VX-770"]}],"arms":[{"label":"Lumacaftor/Ivacaftor (LUM/IVA)","type":"EXPERIMENTAL"}],"summary":"This is a Phase 3, 2-part (Part A and Part B), open-label, multicenter study evaluating the pharmacokinetics (PK), safety, tolerability, and pharmacodynamics (PD) of multiple doses of lumacaftor/ivacaftor (LUM/IVA) in subjects 2 through 5 years of age (inclusive) with cystic fibrosis (CF), homozygous for F508del. Subjects who participate in Part A may participate in Part B, if they meet the eligibility criteria.","primaryOutcome":{"measure":"Part A: Pre-dose Concentration (Ctrough) of LUM and IVA","timeFrame":"Day 15","effectByArm":[{"arm":"Part A (<14 kg Weight): LUM 100 mg/IVA 125 mg","deltaMin":8710,"sd":3590},{"arm":"Part A (>=14 kg Weight): LUM 150 mg/IVA 188 mg","deltaMin":12300,"sd":5960}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":20,"countries":["United States","Canada"]},"refs":{"pmids":["30686767"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":4},"commonTop":["Cough","Vomiting","Pyrexia","Rhinorrhoea","Nasal congestion"]}}